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ABSTRACT
PrimPol is a primase-polymerase found in humans,
and other eukaryotes, involved in bypassing le-
sions encountered during DNA replication. PrimPol
employs both translesion synthesis and repriming
mechanisms to facilitate lesion bypass by the repli-
some. PrimPol has been reported to be a poten-
tial susceptibility gene associated with the develop-
ment of myopia. Mutation of tyrosine 89 to aspartic
acid (PrimPolY89D) has been identified in a number of
cases of high myopia, implicating it in the aetiology
of this disorder. Here, we examined whether this mu-
tation resulted in any changes in the molecular and
cellular activities associated with human PrimPol.
We show that PrimPolY89D has a striking decrease
in primase and polymerase activities. The hydropho-
bic ring of tyrosine is important for retaining wild-
type extension activity. We also demonstrate that the
decreased activity of PrimPolY89D is associated with
reduced affinities for DNA and nucleotides, resulting
in diminished catalytic efficiency. Although the struc-
ture and stability of PrimPolY89D is altered, its fidelity
remains unchanged. This mutation also reduces cell
viability after DNA damage and significantly slows
replication fork rates in vivo. Together, these find-
ings establish that the major DNA replication defect
associated with this PrimPol mutant is likely to con-
tribute to the onset of high myopia.
INTRODUCTION
Cells are required to replicate their genomes in a faithful
way to avoid mutagenesis thus maintaining genetic stabil-
ity. However, DNA is highly prone to damaging agents, in-
cluding oxygen-free radicals, ultraviolet (UV) light, ionizing
radiation and desiccation, resulting in the production of le-
sions and breaks that disrupt the structure of the double
helix. One of the many undesirable consequences of such
damage is the disruption of the progression of DNA repli-
cases (1), which copy the genetic material. These replica-
tion machines are exquisitely sensitive to the conformation
of the template and are prone to stalling upon encounter-
ing DNA damage. To overcome such genetic obstacles, cells
have evolved a variety of lesion tolerance pathways to allow
bypass of damage and resumption of replication (2,3).
PrimPol is a recently characterized primase-polymerase,
belonging to archaeo-eukaryotic primase (AEP) superfam-
ily, that is involved in lesion bypass during both nuclear and
mitochondrial replication in eukaryotic cells (4–6). PrimPol
is required for the replication past particular lesions, such as
UV photoproducts, that block the cellular replication ma-
chinery. It can deploy two differentmechanisms, utilizing ei-
ther of its polymerase and primase activities to facilitate effi-
cient lesion bypass. PrimPol can replicate directly through a
number of obstructing lesions by translesion DNA synthe-
sis (TLS) and it can also reprime replication post-damage
to facilitate fork restart (4,7,8), although the exact timing
of their usage remains to be established. PrimPol knockout
cells are sensitive to damaging agents (e.g. UV, 4NQO and
MMS) and murine PrimPol−/− cells show significant lev-
els of DNA breaks, particularly after treatment with agents
that stall replication (4).
Although recent studies have established the importance
of PrimPol in damage tolerance during DNA replication
in cellular and animal model systems, its association with
human diseases has only been conjectured. However, ex-
ome sequencing of the genomes of candidate patients has
recently implicated the PrimPol gene as a possible suscepti-
bility gene associated with highmyopia (9). This study iden-
tified a missense mutation in human PrimPol caused by a
thymine to guanine transversion, resulting in the substitu-
tion of tyrosine at position 89 by an aspartic acid residue
(Y89D). This mutation was not only found in a single fam-
ily but also four additional sporadic patients with high my-
opia and these patients had high refractive errors (−6.5 to
−32.15 diopters, D) (9). Myopia, or short-sightedness, is
a common problem around the world in those with visual
defects and this problem is rapidly increasing. Myopia ac-
counts for 41% of decreased vision in Western populations
and this up from 25% in the early 1970s (10). In some South-
East Asian populations up to 80–90% of all children leaving
*To whom correspondence should be addressed. Tel: +44 1273 877 500; Fax: +44 1273 678 121; Email: a.j.doherty@sussex.ac.uk
†The authors wish it to be known that, in their opinion, these two authors contributed equally to the work.
C© The Author(s) 2014. Published by Oxford University Press on behalf of Nucleic Acids Research.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which
permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
 at Sussex Language Institute on N
ovem
ber 19, 2014
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
Nucleic Acids Research, 2014, Vol. 42, No. 19 12103
school are now myopic (11). Notably 10–20% of these chil-
dren suffer from high myopia, an extreme form of the dis-
ease, often characterized by a refractive error of less than
−6.00 D and is often associated with other serious ocular
disorders (11,12). The aetiology of high myopia remains ex-
tremely complex and involves the synergy between a num-
ber of genes.
The active site of PrimPol is predicted to consist of three
magnesium-coordinating, negatively charged residues: an
aspartate at residue 114, a glutamate at residue 116 and an
aspartate at residue 280 (4). Although the tyrosine at posi-
tion 89 is not predicted to reside directly within the active
site, it is in close proximity and therefore may play yet un-
determined roles in the activities associated with these en-
zymes. The mutated tyrosine (Y89) is a highly conserved
residue across a wide array of chordate species (Figure 1)
and PolyPhen-2 prediction programme indicates that mu-
tation of this residue would be functionally damaging (9).
In addition to PrimPol, this tyrosine is also present in the
related predicted primase PF14 0050 in plasmodium falci-
parum, so its evolutionary conservation is indicative of a
significant functional residue (13).
In this study, we aimed to characterize the biochemical
properties of the Y89D mutant of PrimPol (PrimPolY89D)
to determine if this amino acid change alters PrimPol’s
activities thus establishing a molecular basis for its pro-
posed involvement in high myopia. Here, we demonstrate
that the Y89D mutant loses its ability to prime using ri-
bonucleotides (rNTPs), but can still prime using deoxyri-
bonucleotides (dNTPs). PrimPolY89D has a greatly reduced
template-dependent processivity activity, when compared
with the wild-type enzyme. In addition, we report that this
mutant has significantly reduced binding for bothDNAand
dNTPs but its fidelity remains largely unchanged. Further-
more, we show that it is the hydrophobic ring of the tyrosine
at position 89 that is important for maintaining these activ-
ities. We also demonstrate that changes in enzyme activity
are the result of global changes in the structure of the poly-
merase domain of PrimPol. Finally, we report that this mu-
tation significantly slows replication fork rates in vivo and
reduces cell viability after DNA damage. Together, these
data establish that a point mutation identified in PrimPol
frompatients with highmyopia results in amajor disruption
of the catalytic and replication activities associated with hu-
man PrimPol thus establishing a link between replication
stress and human disease, particularly high myopia.
MATERIALS AND METHODS
Construction of human PrimPol mutants
Wild-type human PrimPol was cloned as described previ-
ously (4). PrimPolY89D, PrimPolY89F and PrimPolY89S were
cloned by site-directed mutagenesis using the primers that
can be found in Supplementary Table S1. PrimPol1–354 was
cloned as described previously (14) and PrimPolY89D1–354
was cloned by site-directed mutagenesis from this construct
using the primers in Supplementary Table S1.
Expression and purification of recombinant PrimPol proteins
Wild-type PrimPol, PrimPolY89D, PrimPolY89F and
PrimPolY89S were expressed in BL21 (pLysS) Es-
cherichia coli cells overnight at 16◦C and PrimPol1–354
and PrimPolY89D1–354 were expressed overnight at 25◦C.
The proteins were then purified as described previously
(14). Protein concentrations were determined using the
absorbance at 280 nm and the extinction coefficient for
each of the protein constructs.
DNA primase assays
DNA primase assays were carried out as described previ-
ously (14). The templating oligonucleotide sequences can be
found as sequences 1–4 in Supplementary Table S2. Prod-
ucts were resolved on a 15% (v/v) polyacrylamide gel con-
taining 7Murea and 1×TBE buffer at 850 V for 2.5 h in 1×
TBEbuffer. Fluorescently labelledDNAoligomers were de-
tected by scanning using a FujifilmFLA-5100 image reader.
DNA primer extension assays
Polymerase activity was determined by DNA primer exten-
sion assays. Hex-labelled fluorescent primers were annealed
to unlabelled templates (sequences in Supplementary Table
S2). Note that 100 nM of enzyme was incubated at 37◦C
with 20 nM DNA, 10 mM Bis-Tris-Propane-HCl (pH 7.0),
10 mM MgCl2, 1 mM DTT and 200 M dNTPs (Roche)
to a final volume of 20 l for time points increasing up
to 60 min. Reactions were quenched using 2× stop buffer
(95% formamide, 0.09% xylene cyanol, 0.05% bromophe-
nol blue, 200 nM competitor oligonucleotide) and boiled at
95◦C for 5 min. Products were resolved by electrophoresis
as in the DNAprimase assays. For assessment of the fidelity
of PrimPolY89D, oligonucleotides with two adjacent, identi-
cal bases downstream of the primer were incubated, along
with 100 nM enzyme, with single nucleotides for 20 min at
37◦C and were subsequently resolved as above.
Electrophoretic mobility shift assays (EMSAs)
EMSAs were carried out on an overhanging DNA sub-
strate (sequences 5 and 6 annealed from Supplementary
Table S2). Varying concentrations of PrimPol1–354 and
PrimPolY89D1–354 were added to 60 nM DNA, 10 mM Bis-
Tris-Propane-HCl (pH 7.0), 10 mM MgCl2 and 1.0 mM
DTT to a final volume of 20 l and incubated at 25◦C for
60 min. The reactions were supplemented with 2 l 25%
(w/v) ficoll. Samples were resolved by electrophoresis on a
5% (v/v) polyacrylamide gel containing 0.5× TBE buffer at
150V for 0.5 h, then 300V for 2.5 h in 0.5×TBEbuffer. Flu-
orescently labelled DNA oligomers were detected by scan-
ning using a Fujifilm FLA-5100 image reader.
Single turnover kinetic assays
The single turnover assays were based on a previously de-
scribed protocol (15). Hex-labelled fluorescent DNA (20
nM; sequences 6 and 11 annealed from Supplementary Ta-
ble S2) was incubated with wild-type and Y89D PrimPol
(200 nM). The DNA/PrimPol mixture was incubated with
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Figure 1. PrimPolY89D mutation is located adjacent to active siteMotif I. An alignment of PrimPol protein sequences from a variety of chordates, including
examples of mammals, reptiles, amphibians, birds and fish. The position of the mutated tyrosine 89 in human PrimPol is denoted by an arrow and is labelled
‘Y89’. The relative proximity of this residue to the catalytic motifs (I–III) is shown in the AEP domain. The zinc finger domain is denoted by ‘Zfn’.
varying concentrations of dATP for time points ranging
from 0.5 to 60 min and each reaction was carried out in
triplicate. Reactions were quenched by the addition of 2×
stop buffer. The products were resolved by electrophoresis
as in the primase assays. The concentrations of extended
and unextended fluorescent DNA primers were measured
using ImageQuant software (GE Life Sciences). The con-
centration of extended product relative to total fluorescent
DNA loaded was plotted as a function of time and the data
were fit to a single-exponential curve to obtain the kobs for
the different dATP concentrations using the following ex-
ponential equation:
[product] = A(1 − e−kobst)
A secondary plot of kobs as a function of dATP concen-
tration was fitted to the following hyperbolic equation:
kobs = kpol[dATP]Kd(dNTP) + [dATP]
where kpol is the rate of polymerization and Kd(dNTP) is the
equilibrium dissociation constant for dATP.
DNA extension processivity assays
The PrimPol variants were analysed for processivity as
described previously (16). PrimPol (100 nM) was pre-
incubated at 37◦C with 60 nM substrate DNA (sequences
5 and 6 annealed in Supplementary Table S2), 10 mM Bis-
Tris-Propane-HCl (pH 7.0), 10 mMMgCl2 and 1mMDTT
for 30 min. Reactions were initiated by adding deoxyri-
bonucleotides and excess sonicated herring sperm DNA (1
mg/ml) as an enzyme trap. Reactions were quenched after
time points of 15, 30, 60, 120 and 360 s with addition of
2× stop buffer and boiled at 95◦C for 5 min. Samples were
resolved by electrophoresis as described above.
Circular dichroism (CD) spectroscopy
Samples were buffer exchanged into a buffer of 400 nM
NaF, 15 mM Tris-HCl (pH 7.5) and concentrated to 3
mg/ml. The concentration of recombinant protein was de-
termined before and after the CD scans, to ensure accurate
secondary structure predictions. Samples were placed in a
0.1 mm quartz cuvette (Starna, Essex, UK) and measure-
ments were taken using a JASCO J-715 spectropolarimeter
(JASCO). The CD spectrum of the empty buffer was sub-
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tracted from that of the sample and time constant was set to
4 s with a scan rate of 50 nm/min. The bandwidth was 1 nm
and the sensitivity set to standard. Scans were performed in
triplicate from 320 to 180 nm with a 0.1 nm data pitch and
continuous scan mode. A Peltier device was used to main-
tain a temperature at 20◦C.
Protein denaturation curves
The PrimPol1–354 and PrimPolY89D1–354 constructs were
both buffer exchanged into a buffer of 200 mM NaF, 15
mM Tris-HCl (pH7.5). Note that 45 l of 1 Mprotein so-
lution was added to 15 l of SYPRO Orange, resulting in a
final protein concentration of 0.75 M. A control of 45 l
was also added to 15 l of SYPRO Orange. 20 l of each
sample was aliquoted in triplicate into a 96-well plate. Pro-
tein melting experiments were carried out using the Light-
Cycler 480 System II (Roche). The instrument was config-
ured with a detection format of 465 nm as the wavelength of
excitation and 580 nm as the emission wavelength to detect
SYPROOrange-specific signal. Denaturation curve fluores-
cent signal was acquired within a range of 20◦C–80◦C using
a ramping rate of 0.03◦C s−1 and an acquisition of 20 data
points per degree celsius. Melting temperatures (Tm) were
determined through the measurement of the lowest point
of the negative differential of the denaturation curve. Data
was corrected for the background signal of the buffer con-
ditions.
Complementation and survival assays in PrimPol−/− avian
cells
DT40 cells were grown at 39◦C in RPMI 1640 medium
supplemented with 10 M -mercaptoethanol, 1% L-
glutamine, 1% penicillin streptomycin, 10% fetal calf serum,
1% chicken serum (Sigma). PrimPol−/− cells were comple-
mented with human PrimPolY89D cloned into pCI-neo as
described previously (14) and expression was confirmed by
western blotting alongside wild-type complemented stable
cells generated previously (14). DNA replication fork speed
and stalling after UV damage was measured by fibre anal-
ysis as described previously and carried out in triplicate
(4). Cell survival after UV-C damage was measured using
CellTiter-blue (Promega). Briefly, 40 × 104 cells (or a serial
dilution for decreased damage) were resuspended in a small
volume of phosphate buffered saline and exposed to in-
creasing doses of UV-C, media was replaced and cells were
grown for 48 h. Cells were then transferred to 96-well plates
and viability was measured with CellTiter-blue.
RESULTS
PrimPolY89D retains DNA primase but loses its RNA primase
activity
To determine if PrimPol displays an underlying biochemi-
cal defect that contributes to the high myopia clinical phe-
notype, we first examined the primase activity of the Prim-
Pol Y89D (PrimPolY89D) variant. De novo primer synthe-
sis remained largely unchanged between the mutant and
the wild-type in the production of DNA primers from
dNTPs (Figure 2). However, unlike the wild-type enzyme,
29nt 
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Primer 
synthesis 
Probe 
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13nt 
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+ + + + 
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PrimPolY89F  PrimPolY89S 
A        B 
C         D 
Figure 2. Primase activities of human PrimPol and PrimPolY89D. (A) Hu-
man PrimPol has primase activity and can produce de novo primers using
rNTPs and dNTPs in a homo-polymer template-dependent fashion. (B)
PrimPolY89D partially loses its primase activity. This variant of PrimPol
cannot synthesize RNA primers but is an active primase utilizing dNTPs.
(C) PrimPolY89S shows significant loss of the enzymatic activity with resid-
ual primase activity observed in presence of dNTPs. (D) PrimPolY89F is
an active primase variant capable of synthesizing both RNA and DNA
primers with efficiency comparable to wild-type PrimPol.
PrimPolY89D was unable to synthesize RNA primers in the
presence of even high concentrations of rNTPs.While it has
been reported that PrimPol is more proficient at producing
DNA over RNA primers in vivo, we remained intrigued as
to why this mutation in PrimPol conferred a defect in RNA
primer synthesis. To determine whether this disruption in
activity was a result of the carboxylic acid moiety of the as-
partate or was due to the removal of the hydrophobic ring
of tyrosine, we produced two additional PrimPol variants,
Y89S and Y89F. The serine side-chain of Y89S could dis-
criminate whether the charge of the aspartate caused the al-
tered activity we observed with Y89D while retaining the
hydroxyl group of tyrosine, and the phenylalanine of Y89F
could help determine if it was the hydrophobic ring of tyro-
sine that was important for retaining rNTP primase activ-
ity. Upon testing Y89S and Y89F for primase activity (Fig-
ure 2), we found that the PrimPolY89S has an activity com-
parable to Y89D but the Y89F variant of PrimPol returned
primase activity back to wild-type, restoring the ability of
the enzyme to produce RNA primers.
PrimPolY89D mutant has limited processivity
PrimPol comprises two intrinsic catalytic activities. To de-
termine any catalytic deficiencies associated with the Y89D
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Figure 3. Primer extension activities of human PrimPol and PrimPolY89D.
(A)HumanPrimPol has primer extension activity and produces full-length
templates following incubation for up to 60 min (lane 1 is a control and
lanes 2–6 represent time points at 0.5, 1, 3, 5 and 60 min). (B) PrimPolY89D
shows amarked reduction in polymerase activity, incorporating up to eight
nucleotides following incubation for 60 min. (C) PrimPolY89S also shows
a loss in polymerase activity relative to wild-type PrimPol, though it is a
more active polymerase than PrimPolY89D. (D) PrimPolY89F restores poly-
merase activity. The Y89F variant can fully extend primers but there is an
increased level of unextended primer relative to wild-type PrimPol.
point mutation, we must also consider its polymerase ac-
tivity in addition to its primase activity (Figure 3). Primer
extension assays on PrimPol showed that the polymerase ac-
tivity of PrimPolY89D was significantly reduced in compari-
son to the wild-type enzyme. We next tested if this activity
was restored by either Y89S or Y89F variants of PrimPol
(Figure 3) and observed that Y89S had slightly higher activ-
ity than the Y89D variant but was not restored to wild-type
levels. In contrast, Y89F was fully proficient at extending
primers opposite a templating strand. Notably, although
PrimPolY89F was able to fully extend primers, and showed
full extension at time points as short as 3 min (Figure 3D,
lane 4), more primers were left unextended compared with
wild-type PrimPol, suggesting that this enzyme has higher
activity once it has bound DNA but coordinates it less effi-
ciently.
PrimPol was previously shown to be a distributive DNA
polymerase, inserting only up to four nucleotides during
a single binding event (Figure 4). We next determined
whether the processivity of the mutant was altered, caus-
ing the observed reduction in the polymerase activity.
PrimPolY89D variant could only insert a single nucleotide
opposite a templating strand of DNA, making it an even
more distributive enzyme than wild-type PrimPol (Fig-
Con 
   Time 
Con 
Con 
Wild-type PrimPol PrimPolY89D 
PrimPolY89S 
Con 
PrimPolY89F  
Time 
     A         B 
C   D 
Time Time 
Figure 4. Processivity of human PrimPol and PrimPolY89D. Primer exten-
sion assays were performed in the presence of an excess of herring sperm
DNA trap to ensure the polymerase only binds once to the template DNA.
Control reactions were also carried out to test the effectiveness of the trap
DNA (data not shown). The first lanes represent a no-enzyme control and
lanes 2–6 represent time points of 15, 30, 60, 120 and 360 s. (A) Human
PrimPol is a poorly processive enzyme, inserting up to four nucleotides op-
posite a templatingDNA strand in a single binding event. (B) PrimPolY89D
has marked reduction in processivity, and is only able to insert a single nu-
cleotide opposite a templating DNA strand per single binding event. (C)
PrimPolY89S can also insert only one single nucleotide opposite a templat-
ing DNA strand. (D) PrimPolY89F restores processivity and has the ability
to insert up to four nucleotides, similarly to wild-type PrimPol.
ure 4). To determine whether the aromatic ring of tyrosine
was the main determinant for enzyme activity, we tested the
processivity activities of Y89S and Y89F variants. Consis-
tent with Y89D, PrimPolY89S could only insert a single nu-
cleotide. However, in common with the wild-type enzyme,
PrimPolY89F could insert up to four nucleotides. This estab-
lishes that the presence of an aromatic side-chain at this po-
sition is requisite for maintainingmore processive extension
by PrimPol.
Reduced DNA binding contributes to the low processivity of
PrimPolY89D
A reduction in processivity can be attributed to alter-
ations in either dNTP or substrate DNA binding. To
test the binding efficiencies of wild-type and PrimPolY89D,
we introduced the mutation into the polymerase domain
(PrimPol1–354) of PrimPol. This ensured that the contribu-
tory binding effects of the zinc finger were removed to en-
able assessment of the alteration in binding caused solely
by this point mutation in the polymerase domain. As the
polymerase domain is able to bind both single- and double-
stranded DNA (14), we chose to use a labelled overhang-
ing DNA substrate in our EMSAs, similar to the substrates
PrimPol would encounter in vivo. The binding efficiency of
PrimPol1–354Y89D to DNAwas almost four times lower than
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PrimPol1–354. The wild-type KD(DNA) was 0.67 M, com-
pared with Y89D KD(DNA) of 2.55 M (Figure 5).
PrimPolY89D has reduced dNTP binding but its fidelity is not
altered
To evaluate the effects of this mutation on the enzymatic
properties of PrimPol, a kinetic analysis was performed to
determine the catalytic efficiency (kpol) and binding con-
stants for dATP (KD(dNTP)) opposite a templating thymine
(Supplementary Figure S1). We found the wild-type kpol to
be 6.98 min−1 and the KD(dNTP) to be 15.51 M (Figure 6).
PrimPol is an extremely slow enzyme––for comparison the
kpol of base excision repair enzyme DNA polymerase  is
1944 min−1 (17). We determined the Y89D variant of Prim-
Pol to be a slightly slower polymerase, with a kpol of 4.07
min−1 and binds dNTPs over 10-fold less competently, with
a KD(dNTP) of 170.21 M (Figure 6). The reduction in cat-
alytic efficiency and dramatic reduction in dNTP binding
may or may not be dependent on the initial binding of
DNA.
If dNTP coordination had been severely affected in the
Y89D variant, we would expect quite a deviation fromwild-
type PrimPol in the fidelity of nucleotide incorporation.
However, we found that the Y89D variant of PrimPol did
not have any appreciable variation from the wild-type en-
zyme in terms of fidelity (SupplementaryFigure S2). If there
was an alteration in the coordination of incoming dNTPs,
there would also be a lower probability that this enzyme
would be able to bypass the highly distortive lesions that the
wild-type enzyme could bypass. However, we observed that
PrimPolY89D was able to synthesize through even highly dis-
tortive lesions, such as a 6–4 photoproduct (Supplementary
Figure S3).
Aromatic residues often act as a steric gate for sugar dis-
crimination (18). Mutation of these key residues can result
in the incorporation of rNTPs instead of dNTPs opposite
a templating DNA strand (19). PrimPolY89D, like wild-type
PrimPol, was also unable to extend primers using rNTPs
(Supplementary Figure S4). Therefore, it is highly unlikely
that this tyrosine residue is involved in discerning the sugar
of the incoming nucleotide, particularly as the Y89D vari-
ant also loses its ability to prime using rNTPs.
Y89D mutation induces significant structural changes to
PrimPol
The observed reduced enzyme activity of PrimPolY89D
could be the result of the loss of aromatic interactions in-
volved in local base stacking events with either the tem-
plate or the incoming nucleotide. However, it may instead
be required for maintaining the structural integrity of the
enzyme and mutation of this tyrosine causes more global
effects in the structure of PrimPol. To test this second pos-
sibility, we subjected the polymerase domains of both the
wild-type and PrimPolY89D to thermal denaturation and
CD to check for alterations. There was a striking differ-
ence in both the thermal denaturation profiles and the CD
spectra of the two enzymes (Figure 7), suggesting this point
mutant results in global changes to the enzyme that causes
the reduction in activity observed above. The melting point
of the polymerase dropped from 49.12◦C for the wild-type
polymerase domain compared to 42.50◦C for PrimPolY89D
(Figure 7A). This significant drop in melting temperature
suggests that the enzyme has become less stable and more
structurally disordered following the point mutation. Anal-
yses of the secondary structure from the CD spectra of the
two variants’ polymerase domains by the variable selection
algorithm (CDSSTR) (20), which provides better fits for
globular proteins, revealed a difference in the -helical con-
tent of these domains (37% for wild-type PrimPol compared
with 21% for Y89D), as well as -strand content (25% for
wild-type compared with 29% for Y89D). Additionally, this
analysis predicted 30% of the structure of the PrimPolY89D
polymerase domain to be unstructured, whereas just 24% of
wild-type was predicted to be unstructured.
PrimPolY89D significantly decreases DNA replication fork
rates in vivo
To gain further insights into how the Y89Dmutant form of
PrimPol may contribute to the myopic phenotype observed
in human patients, we studied the influence of PrimPolY89D
on DNA replication in damaged and undamaged cells. We
utilized a DT40 PrimPol deleted cell line (PrimPol −/−) (4)
to examine the ability of PrimPolY89D to complement this
loss, as previously reported for other mutant forms of Prim-
Pol (14). We stably expressed human PrimPolY89D at simi-
lar levels to WT PrimPol in PrimPol knockout cells (Fig-
ure 8A), with no obvious effects on cell growth.
We reported previously that PrimPol−/− cells have a
greater sensitivity to UV irradiation thus we first exam-
ined the effects of increasing doses of UV-C on PrimPolY89D
complemented cell lines. Although PrimPol−/− cells com-
plemented with wild-type PrimPol showed a reversal of
this sensitivity, cells complemented with PrimPolY89D main-
tained a decreased viability after UV damage (Figure 8B).
Next, we measured the replication fork speeds in Prim-
Pol complemented cell lines using DNA fibre analysis,
as previously described (4,14). Strikingly, we observed a
dramatic decrease in fork speeds in cells complemented
with PrimPolY89D (0.84 kb/min) compared with cells car-
rying the wild-type PrimPol (1.66 kb/min) (Figure 8C).
This decrease in fork speed was significantly greater than
that previously reported in PrimPol−/− cells (1.45 kb/min;
(4,14)), suggesting the Y89D mutant form of PrimPol may
actually impede on-going DNA replication. In contrast,
PrimPolY89D complemented the increased stalling defect
observed in PrimPol−/− cells treated with UV-C, equally as
well as WT PrimPol (Figure 8D).
DISCUSSION
A recent exome sequencing study has implicated a point
mutation (Y89D) in the DNA damage tolerance poly-
merase, PrimPol, in high myopia in human patients. How-
ever, this report did not investigate the molecular conse-
quences of this genetic alteration. Here, we report that the
Y89D variant of PrimPol, previously found to be associated
with high myopia, is a low processivity variant of PrimPol.
Unlike wild-type PrimPol, it inserts just one nucleotide in
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Figure 5. DNA binding efficiency of polymerase domains of wild-type and PrimPolY89D. (A) The polymerase domains (PrimPol1–354) for both wild-type
and PrimPolY89D were used to eliminate the effects of binding from the zinc finger domains. Wild-type PrimPol domain bound to DNA at a much lower
concentration than PrimPolY89D as determined by EMSAs. The concentrations used in both of these EMSAs were 0, 0.01, 0.025, 0.05, 0.075, 0.1, 0.25, 0.5,
0.75, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 5 and 10 M. (B) These assays were subsequently quantified to determine KD(DNA) values for the polymerase
domains of wild-type PrimPol (solid green line) and its Y89D variant (broken purple line). KD(DNA) of wild-type PrimPol was 0.69 M, while the KD(DNA)
of PrimPolY89D was 2.55 M.
a single binding event and has a significantly lower affinity
for both dNTPs andDNA.Notably, this mutant did not ex-
hibit any alteration in the fidelity or TLS spectrum relative
to wild-type PrimPol. To determine whether this altered ac-
tivity was a result of losing the hydrophilic hydroxyl moiety
or the hydrophobic ring moiety, we constructed two more
variants in which tyrosine 89 was mutated to either pheny-
lalanine or serine. The Y89F mutant restored processivity
to near-wild-type levels but Y89S had a similar activity to
Y89D. In addition, we found that the Y89D PrimPol vari-
ant was unable to produce ribonucleotide primers, but this
activity was restored in the Y89F variant, indicating that
PrimPol requires a hydrophobic aromatic ring at position
89 to maintain processivity but the presence of a hydroxyl
moiety is dispensable.
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Figure 6. Kinetic analysis of human PrimPol and PrimPolY89D. Single
turnover kinetics of wild-type and PrimPolY89D to determine catalytic ef-
ficiency (kpol) and dNTP binding efficiency (KD(dNTP)). (A) The concen-
tration of extended DNA product, as determined by electrophoresis, was
plotted against time and fit to an exponential curve for a number of dATP
concentrations for wild-type and PrimPolY89D. These data were fit to ex-
ponential curves as described in Equation (1) and kobs was determined.
(B) kobs was subsequently plot against dATP concentration for wild-type
PrimPol and PrimPolY89D and these data were fit to hyperbolic curves as
described in Equation (2) to determine kpol and KD(dNTP). kpol for wild-
type PrimPol was found to be 6.98 min−1 ± 0.40 and KD(dNTP) was 15.51
M± 2.71. kpol for PrimPolY89D was 4.07min−1 ± 0.19 andKD(dNTP) was
170.21 M ± 18.80.
Insights from structural studies on primases and poly-
merases suggest two different potential explanations for
the reduction in polymerase processivity observed in this
study. The conserved tyrosine at position 89 could have an
important role in base stacking or could be required for
the structural integrity of the protein. There is an invari-
ant phenylalanine in nonhomologous end-joining (NHEJ)
AEPs that plays a vital role in the recognition and orienta-
tion of both the templating and the incoming bases through
stacking interactions with both bases and is responsible for
moving the incoming nucleotide into the enzyme’s active
site (21,22). Phenylalanine 290 in human Pol  helps form
the hydrophobic core of the thumb domain (23). Mutation
of this residue is associated with the genetic disorder xe-
roderma pigmentosum variant, which is characterized by a
susceptibility to skin cancers caused by a failure to per-
form proficient TLS opposite UV lesions. This mutation
negates polymerase activity and is predicted to destabilize
the thumb domain, resulting in reduced primer binding.
While the structure of PrimPol has not yet been elucidated,
it is conceivable that the tyrosine at position 89 is involved
in preserving the structure of a domain analogous to the
Figure 7. Y89A induces a structural perturbation in PrimPol. The poly-
merase domain of theY89Dvariant of PrimPol has a different global struc-
ture and thermal stability compared to wild-type PrimPol. (A) Thermal
denaturation of the polymerase domain of PrimPol and its Y89D variant.
The negative differential of the fluorescence profiles of the polymerase do-
mains (PrimPol1–354) of wild-type PrimPol (solid green line) and its Y89D
(broken purple line) variant plotted against temperature to determine their
melting points. The melting point of the polymerase domain of the wild-
type enzyme was found to be 49.12◦C, while the Y89D variant had a con-
siderably lowermelting point at 42.50◦C. (B) CD spectra of the polymerase
domains of wild-type PrimPol and PrimPolY89D show a substantial differ-
ence in the global structure of PrimPolY89D relative to the wild-type en-
zyme.
thumb domain that is found in other polymerases involved
in binding/coordinating the templating DNA strand. Tyro-
sine 89 is situated in a conserved hydrophobic pocket con-
taining other conserved aromatic residues including Y87,
F88 and Y90, as well as a hydrophobic residue at position
86 (Figure 1) and it is likely that disruption of Y89 dis-
rupts a conserved interaction between these amino acids.
A secondary structure prediction from PSIPRED (24) pre-
dicts that all of these amino acids lie within an -helical
region and the Y89 mutation may disrupt this helix. The
CD data certainly supports this model, indicating that the
Y89Dvariant has less-helical structure than thewild-type.
We postulate that the Y89D mutation causes a disruption
in the global structure of the polymerase domain of Prim-
Pol. As the affinity for DNA and dNTPs is decreased in the
Y89D variant, but the apparent fidelity of the enzyme re-
mains unchanged, we suggest that dNTP binding is depen-
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Figure 8. PrimPol Y89D cannot fully complement the UV sensitivity seen
in PrimPol−/− DT40 cells due to decreased replication fork speeds. (A)
Western blot showing overexpression of wild type and Y89D point mutant
forms of PrimPol in PrimPol knockout (PrimPol−/−) DT40 chicken cells.
(B) Cell viability was measured using CellTiter-Blue 48 h after increasing
doses of UV-C were administered to the different cell types. Results repre-
sent three independent repeats and the error bars represent the standard
deviation across the repeats. (C) DNA fibres were measured after sequen-
tial labelling with CldU and IdU for 20 min each to calculate replication
speed. Results represent three independent repeats. (D) A 20 J/m2 UV-C
pulse was included between the two labels and the ratio of the pre- and
post-UV-C labels was calculated, with increased ratios representing repli-
cation stalling after UV. Results represent three independent repeats.
dent on DNA binding, which is disrupted by the structural
changes induced by this mutation.
In vivo analysis identified a dramatic decrease in repli-
cation fork rates in cells expressing PrimPolY89D and, de-
spite being able to complement fork stalling in PrimPol−/−
cells after UV damage, it was unable to prevent decreased
cell viability. Consistent with in vitro assays, PrimPolY89D
causes decreased replication fork rates in cells and it ap-
pears that this defect is enough to decrease the damage tol-
erance of these cells. Both our in vivo and in vitro studies
on this mutant indicate that although PrimPolY89D retains
the ability to bypass lesions, its capacity to replicate DNA is
severely compromised. Therefore, it appears that although
PrimPolY89D is recruited to stalled replisomes, the underly-
ing replication defect causes a significant slowing of repli-
cation forks, potentially resulting in incomplete lesion by-
pass, causing cells to progress through the cell cycle with
underreplicated genomic DNA. Clearly, these cells carry an
abundance of PrimPol compared to wild-type levels and
thus replication fork speed alone in endogenous mutants
may not be so significantly altered. However, in cases where
PrimPol is actively recruited to on-going forks or damage
sites, this ‘slow’ mutant is likely to cause significant prob-
lems. Therefore, unexpectedly, it appears that harbouring
the PrimPolY89D mutation ismore detrimental than not hav-
ing PrimPol at all. This data correlates with the phenotypes
observed in patients carrying this mutation as problems are
observed in tissues where levels of UV damage are expected
to be high. Thus, in tissues where PrimPol is recruited in
higher abundance to replicate through DNA damage, such
as eyes, cellular defects aremuchmore likely to be prevalent.
The link between reduced PrimPol polymerase activity
and myopigenicity remains unclear. Previous studies into
the genes that predispose high myopia have identified two
clusters of mutations, one in the outer retina affecting pho-
toreceptors andON-bipolar cell function and another in the
scleral extracellular matrix composition and metabolism
(11). Significantly, mutations in PrimPol do not fit into ei-
ther category. The severity of the clinical phenotype of pa-
tients with the Y89D mutation varied (9) and it is highly
likely that this gene is not a singular, unique aetiological
factor and that other genetic and environmental factors also
contribute to pathogenesis. Although replication defects as-
sociatedwith PrimPolY89D suggests that it contributes to the
reported clinical phenotypes, further work is required to es-
tablish if a direct link exists between replication stress and
onset of high myopia.
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